Assessment of three chromogenic and one clotting assays for the measurement of synthetic pentasaccharide fondaparinux (Arixtra) anti-Xa activity.

作者信息

Depasse F, Gerotziafas G T, Busson J, Van Dreden P, Samama M M

出版信息

J Thromb Haemost. 2004 Feb;2(2):346-8. doi: 10.1111/j.1538-7933.2004.0584a.x.

DOI:10.1111/j.1538-7933.2004.0584a.x

PMID:14996008

Abstract

摘要

相似文献

Assessment of three chromogenic and one clotting assays for the measurement of synthetic pentasaccharide fondaparinux (Arixtra) anti-Xa activity.

J Thromb Haemost. 2004 Feb;2(2):346-8. doi: 10.1111/j.1538-7933.2004.0584a.x.

Effects of pentasaccharide (fondaparinux) and direct thrombin inhibitors on coagulation testing.

Arch Pathol Lab Med. 2004 Oct;128(10):1142-5. doi: 10.5858/2004-128-1142-EOPFAD.

Monitoring effects of direct FXa-inhibitors with a new one-step prothrombinase-induced clotting time (PiCT) assay: comparative in vitro investigation with heparin, enoxaparin, fondaparinux and DX 9065a.

Int J Clin Pharmacol Ther. 2007 Apr;45(4):237-43. doi: 10.5414/cpp45237.

Assessment of laboratory assays to measure rivaroxaban--an oral, direct factor Xa inhibitor.

Thromb Haemost. 2010 Apr;103(4):815-25. doi: 10.1160/TH09-03-0176. Epub 2010 Feb 2.

Two sensitive and rapid chromogenic assays of fondaparinux sodium (Arixtra) in human plasma and other biological matrices.

Clin Lab. 2003;49(9-10):451-60.

Use of the pentasaccharide fondaparinux as an anticoagulant during haemodialysis.

Thromb Haemost. 2007 Dec;98(6):1200-7. doi: 10.1160/th07-07-0444.

Inter-assay and instrument variability of anti-Xa--results.

Thromb Haemost. 2000 Jul;84(1):138.

Evaluation of Factor Xa-Specific Chromogenic Substrate Assays and the Determination of Pharmacokinetics of Fondaparinux.

Clin Appl Thromb Hemost. 2016 Jul;22(5):453-8. doi: 10.1177/1076029615595878. Epub 2015 Jul 15.

Fondaparinux: a Factor Xa inhibitor for antithrombotic therapy.

Expert Opin Pharmacother. 2004 Jun;5(6):1373-84. doi: 10.1517/14656566.5.6.1373.

Edoxaban, a direct factor Xa inhibitor, suppresses tissue-factor induced human platelet aggregation and clot-bound factor Xa in vitro: Comparison with an antithrombin-dependent factor Xa inhibitor, fondaparinux.

Thromb Res. 2016 May;141:17-21. doi: 10.1016/j.thromres.2016.02.028. Epub 2016 Feb 26.

引用本文的文献

Heparins are potent inhibitors of ectonucleotide pyrophosphatase/phospho-diesterase-1 (NPP1) - a promising target for the immunotherapy of cancer.

Front Immunol. 2023 Aug 29;14:1173634. doi: 10.3389/fimmu.2023.1173634. eCollection 2023.

Impaired platelet-dependent thrombin generation associated with thrombocytopenia is improved by prothrombin complex concentrates in vitro.

Res Pract Thromb Haemost. 2020 Feb 14;4(2):334-342. doi: 10.1002/rth2.12310. eCollection 2020 Feb.

Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism.

J Thromb Thrombolysis. 2016 Jan;41(1):165-86. doi: 10.1007/s11239-015-1315-2.

[Anticoagulation].

Med Klin Intensivmed Notfmed. 2013 May;108(4):325-34; quiz 335-6. doi: 10.1007/s00063-013-0243-1.

Role of factor xa inhibitors in cancer-associated thrombosis: any new data?

Adv Hematol. 2011;2011:196135. doi: 10.1155/2011/196135. Epub 2011 Oct 15.

Favorable coagulation profile with fondaparinux after hip surgery in elderly patients.

Int J Hematol. 2009 Nov;90(4):476-482. doi: 10.1007/s12185-009-0425-z. Epub 2009 Oct 17.

New anticoagulants for the prevention and treatment of venous thromboembolism.

Vasc Health Risk Manag. 2005;1(1):41-53. doi: 10.2147/vhrm.1.1.41.58936.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验